Pharmacology Case Study

WHAT YOU NEED TO DO:
1. Answer all the questions asked in the scenario. Refer to required submissions for further guidelines.
REQUIRED SECTIONS
1. Answers to all the questions:
a. Typed and double spaced.
c. Grammatically correct with proper sentence structure.
d. APA format.

2. Other documents:
c. Reference page.

CASE STUDY SCENARIO
Julie is a 52-year-old female who has come to a local walk-in clinic to discuss her COPD and specifically the problem she is having with

exacerbations and time ‘off sick’. She is a heavy smoker, and her progressively deteriorating lung function suggests that she has moderate COPD,

although she also has a history of childhood asthma, and had allergic rhinitis as a teenager.
She has a sedentary office job and, although she is breathless on exertion, this generally does not interfere with her lifestyle. The relatively

frequent exacerbations are more troublesome. They are usually triggered by an upper respiratory infection and can take a couple of weeks to

recover. She has had three exacerbations this winter, and as a result her employer is not happy with her sickness absence record and has asked

her to seek advice from her general practitioner.
Julie is on a short-acting β2-agonist, although she rarely uses it except during exacerbations. In the past, she has used an inhaled steroid,

but stopped that some time ago as she was not convinced it was helping.
While auscultating Julie’s lungs, the nurse hears expiratory wheezes throughout. Her vital signs are as follows: blood pressure 110/82; pulse

116; respiratory rate 39; oxygen saturation on room air is 88%. Recent spirometry showed a typical COPD flow-volume loop, although she had some

reversibility (250 ml and 20%) with a post-bronchodilator FEV1 of 60% predicted.

Questions
1. Julie took her fluticasone (Flovent) puffer before coming to the walk-in clinic. Why was this medication not effective in controlling her

flare of COPD?

2. Identify six (6) clinical manifestations that may suggest Julie is not responding to the current treatment and may progress to respiratory

failure?

3. What are the main adverse effects associated with Flovent use, and how can these effects be minimized?

4. Julie is ready to go home, what specific teaching points pertaining to the correct inhaler technique and order in which the puffers should be

self-administered must the nurse review with Julie?

5. Julie is prescribed theophylline (Theo-Dur) upon discharge. Provide health teaching to Julie regarding this new medication.
6. The nurse realizes Julie’s COPD has various triggers. Discuss with Julie the importance of identifying and avoiding potential triggers.

TAKE ADVANTAGE OF OUR PROMOTIONAL DISCOUNT DISPLAYED ON THE WEBSITE AND GET A DISCOUNT FOR YOUR PAPER NOW!

BUY ANSWERS
  • 30% DISCOUNT ON ALL ORDERS!!!
  • Enter the code: AE30
toggle